<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the fact that CHIKV causes disease around the globe, with a significant impact on the quality of patientsâ€™ life as well as the relevant economic burden, no specific anti-viral drugs or/and licensed vaccines are available, to date. Treatment is entirely symptomatic, and only palliative care can be administered (analgesics, antipyretics, non-steroidal anti-inflammatory drugs (NSAIDs), and systemic glucocorticoids in the case of severe and persistent joint pain) [
 <xref rid="B204-viruses-11-00175" ref-type="bibr">204</xref>]. CHIKV infection may not always present specific manifestations, and it may co-exist with other infectious diseases, like dengue or Zika fever [
 <xref rid="B205-viruses-11-00175" ref-type="bibr">205</xref>]. Thus, careful clinical management in the absence of laboratory confirmation is crucial. According to the WHO guidelines, paracetamol is the first-line analgesic treatment, and aspirin or other NSAIDs should be avoided, because of their adverse effects and the increased risk of bleeding manifestations in cases of DENV (co-)infection [
 <xref rid="B206-viruses-11-00175" ref-type="bibr">206</xref>].
</p>
